TLIS - Talis Biomedical Corp
IEX Last Trade
4.41
4.410 100.000%
Share volume: 0
Last Updated: Fri 30 Aug 2024 08:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-03 | 2023-03-22 | 2023-05-11 | 2023-08-10 | 2023-11-14 | 2024-03-28 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 221.690 M | 194.094 M | 169.290 M | 133.053 M | 123.076 M | 107.228 M | 94.674 M | 82.494 M | |
| Current Assets | 173.966 M | 150.377 M | 133.282 M | 115.588 M | 101.965 M | 89.532 M | 77.683 M | 71.170 M | |
| Inventories | 2.219 M | 2.027 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 5.738 M | 4.134 M | 2.783 M | 1.492 M | 2.223 M | 1.531 M | 901.000 K | 827.000 K | |
| Short Term Investments | 5.738 M | 4.134 M | 2.783 M | 1.492 M | 2.223 M | 1.531 M | 901.000 K | 827.000 K | |
| Total Receivables | 636.000 K | 433.000 K | 308.000 K | 127.000 K | 532.000 K | 5.000 K | 50.000 K | 6.000 K | |
| Current Cash | 165.373 M | 143.783 M | 130.191 M | 112.959 M | 98.200 M | 87.996 M | 76.732 M | 70.337 M | |
| Total Non-current Assets | 47.724 M | 43.717 M | 36.008 M | 17.465 M | 21.111 M | 17.696 M | 16.991 M | 11.324 M | |
| Property Plant Equipment | 10.157 M | 6.869 M | 3.312 M | 3.634 M | 3.539 M | 3.332 M | 3.030 M | 1.628 M | |
| Other Assets | 37.567 M | 36.848 M | 32.696 M | 13.831 M | 17.572 M | 14.364 M | 13.961 M | 9.696 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 221.690 M | 194.094 M | 169.290 M | 133.053 M | 123.076 M | 107.228 M | 94.674 M | 82.494 M | |
| Total liabilities | 44.671 M | 41.708 M | 42.551 M | 22.929 M | 26.910 M | 25.672 M | 25.558 M | 25.810 M | |
| Total current liabilities | 13.903 M | 11.378 M | 12.672 M | 11.180 M | 9.262 M | 8.450 M | 8.772 M | 9.471 M | |
| Accounts Payable | 3.978 M | 4.111 M | 3.768 M | 3.871 M | 2.491 M | 2.697 M | 1.339 M | 3.619 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 2.334 M | 2.995 M | 3.703 M | 2.962 M | 2.736 M | 2.861 M | 2.882 M | 2.902 M | |
| Long term debt | 30.768 M | 30.330 M | 29.879 M | 11.749 M | 17.648 M | 17.222 M | 16.786 M | 16.339 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 177.019 M | 152.386 M | 126.739 M | 110.124 M | 96.166 M | 81.556 M | 69.116 M | 56.684 M | |
| Common stock | 1.775 M | 1.776 M | 1.787 M | 1.788 M | 1.817 M | 1.819 M | 1.846 M | 1.822 M | |
| Retained earnings | -425.004 M | -451.025 M | -477.954 M | -495.785 M | -510.819 M | -526.501 M | -539.961 M | -552.996 M |